Skip to content

13F-HR filed by Abingworth LLP

Abingworth LLP filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 11 holding rows worth $129,977,000.

Accession
0000950123-13-006695
Filed
2013-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 11 entries on the cover page, a total value of $129,977,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $129,979,000 with VALUE read as thousands by filing date, 13F file number 028-14285. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerAbingworth Management LTD
  • included managerAbingworth Management LTD

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMARIN CORP PLC023111206SPONS ADR NEW8,087,486$46,827,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock1,240,917$30,502,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM3,600,000$23,184,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock313,053$9,689,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM603,740$5,917,000thousands by filing date
CEMPRA INC15130J109COM714,285$5,593,000thousands by filing date
ZOGENIX INC98978L105COM2,335,218$4,017,000thousands by filing date
ANTHERA PHARMACEUTICALS INC03674U102COM3,503,956$1,727,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM62,500$1,376,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS102,200$879,000thousands by filing date
ZALICUS INC98887C105COM473,800$268,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-13-006695this filing2013-08-14acceptance time not in the bulk data set